Friday, July 10, 2026

Drug profile · INN

protein hydrolysate

protein hydrolysate (AMINOSOL 5%) is an FDA-listed pharmaceutical active ingredient. Route of administration: injection. Current US regulatory status: approved.

FDA: approved
US status approved
Patents linked 0
Pipeline programs 4
News articles 0
Drug details — protein hydrolysate
US status
approved
Class
Route
INJECTION
Patents
0
Programs
4
Data quality
0.84

Quick answer

protein hydrolysate (AMINOSOL 5%) is an FDA-listed pharmaceutical active ingredient. Route of administration: injection. Current US regulatory status: approved.

Key facts

INN protein hydrolysate
Brand AMINOSOL 5%
Route INJECTION
Formulation INJECTABLE

Approval history

Authority Status Date
FDA approved

Pipeline programs

  1. PRO 2000/5 Phase 3 · United Therapeutics Europe · HIV Infections
  2. Protein C Concentrate (Human) Vapor Heated Phase 3 · Takeda · Protein C Deficiency
  3. Pulmonary Rehabilitation (PR) Phase 2 · United Therapeutics Europe · Non-small Cell Lung Cancer Stage III
  4. Amino acid based formula Unknown · United Therapeutics Europe · Cow Milk Allergy

Frequently asked questions

What is protein hydrolysate?

protein hydrolysate (AMINOSOL 5%) is an FDA-listed pharmaceutical active ingredient. Route of administration: injection. Current US regulatory status: approved.

What is the brand name for protein hydrolysate?

AMINOSOL 5% is a marketed brand name for protein hydrolysate. Check FDA Drugs@FDA for the current US label holder and prescribing information.

What is the US approval status of protein hydrolysate?

protein hydrolysate has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.